Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunologic and imaging signatures in post tuberculosis lung disease
S. Singh, B W Allwood, TL Chiyaka, et al.
Tuberculosis (2022) Vol. 136, pp. 102244-102244
Open Access | Times Cited: 19

Showing 19 citing articles:

Post-tuberculosis lung disease and chronic obstructive pulmonary disease
Xiaoyan Gai, Brian Allwood, Yongchang Sun
Chinese Medical Journal (2023) Vol. 136, Iss. 16, pp. 1923-1928
Open Access | Times Cited: 19
The role of Mycobacterium tuberculosis exosomal miRNAs in host pathogen cross-talk as diagnostic and therapeutic biomarkers
Farwa Mukhtar, Antonio Guarnieri, Natasha Brancazio, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 5
Mechanisms of lung damage in tuberculosis: implications for chronic obstructive pulmonary disease
Alex Kayongo, Brian Nyiro, Trishul Siddharthan, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 11
N-acetylcysteine to reduce kidney and liver injury associated with drug-resistant tuberculosis treatment
Idu Meadows, Happiness Mvungi, Kassim Salim, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Vaccination in post-tuberculosis lung disease management: A review of the evidence
Mohammad Javad Nasiri, Denise Rossato Silva, Foad Rommasi, et al.
Pulmonology (2023)
Open Access | Times Cited: 10
Post-tuberculosis lung disease and inflammatory role players: can we characterise the myriad inflammatory pathways involved to gain a better understanding?
Lindiwe Malefane, Gerald J. Maarman
Chemico-Biological Interactions (2023) Vol. 387, pp. 110817-110817
Open Access | Times Cited: 10
Azithromycin as host-directed therapy for pulmonary tuberculosis – a randomized pilot trial
Bart G. J. Dekkers, Huib A.M. Kerstjens, Helene W. Breisnes, et al.
The Journal of Infectious Diseases (2025)
Closed Access
N-Acetylcysteine to Reduce Kidney and Liver Injury Associated with Drug-Resistant Tuberculosis Treatment
Idu Meadows, Happiness Mvungi, Kassim Salim, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 516-516
Open Access
Exploring tumor necrosis factor-alpha as a biomarker for post-tuberculosis pulmonary fibrosis: A case-control study
Muhlisa Muhammed Ali Laila, Mohammed Kaleem Ullah, Sindaghatta Krishnarao Chaya, et al.
Indian Journal of Tuberculosis (2025)
Closed Access
Delineating the Significance of Several Inflammatory Markers in a Lung Tuberculosis Cohort During the Active and Post-Tuberculosis Stages of the Disease: An Observational Study in Cape Town, South Africa (2019 to 2024)
Chrisstoffel Jumaar, Lindiwe Malefane, Steve Jacobs, et al.
Infectious Disease Reports (2025) Vol. 17, Iss. 3, pp. 52-52
Open Access
Brazilian Thoracic Association recommendations for the management of post-tuberculosis lung disease
Denise Rossato Silva, Ana Paula Santos, Dina Visca, et al.
Jornal Brasileiro de Pneumologia (2023), pp. e20230269-e20230269
Open Access | Times Cited: 9
Burden, clinical features, and outcomes of post-tuberculosis chronic obstructive lung diseases
Inderpaul Singh Sehgal, Sahajal Dhooria, Valliappan Muthu, et al.
Current Opinion in Pulmonary Medicine (2023) Vol. 30, Iss. 2, pp. 156-166
Closed Access | Times Cited: 6
Case series of complicated bronchopulmonary lophomoniasis. Differential diagnosis of tuberculosis?
Cristian Morán‐Mariños, Juan A. Salas-López, Félix Llanos-Tejada, et al.
European Clinical Respiratory Journal (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Understanding the Spectrum and Management of Post-Tuberculosis Lung Disease: A Comprehensive Review
Sankalp Yadav, Gautam Rawal
Cureus (2024)
Open Access | Times Cited: 1
POST-TUBERCULOUS OBSTRUCTIVE PULMONARY DISEASE (review of foreign literature)
HADI TLAIS, ELDAR KН. ANAEV
The Bulletin of Contemporary Clinical Medicine (2024) Vol. 17, Iss. 1, pp. 107-118
Open Access
From pathogenesis to antigens: the key to shaping the future of TB vaccines
Haoyan Yang, Xinkui Lei, Siyu Chai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Clofazimine inhibits innate immunity against Mycobacterium tuberculosis by NF-κB
Xinda Li, Xiaoyi Luo, Bin Wang, et al.
mSphere (2024) Vol. 9, Iss. 8
Open Access
Scoping review of post‐TB pulmonary vascular disease: Proceedings from the 2nd International Post‐Tuberculosis Symposium
Elizabeth H. Louw, Jennifer K. van Heerden, Ismail Kalla, et al.
Pulmonary Circulation (2024) Vol. 14, Iss. 3
Open Access
The Incidence, Risk Factors, and Predictive Model of Obstructive Disease in Post-Tuberculosis Patients
Wenjun Chang, Zheng Li, Qianqian Liang, et al.
International Journal of COPD (2024) Vol. Volume 19, pp. 2457-2466
Open Access
Séquelles pulmonaires de tuberculose : une thématique à ne pas négliger pour les pneumologues
F.–X. Blanc
Revue des Maladies Respiratoires Actualités (2023) Vol. 15, Iss. 1, pp. 1S80-1S84
Open Access
The obstructive phenotype of chronic posttuberculosis disease - is there a role for the occupational exposure?
Ioan Anton Arghir, Mihaela Trenchea, Cristiana Libu Calboreanu, et al.
Romanian Journal of Occupational Medicine (2023) Vol. 74, Iss. 1, pp. 36-40
Open Access
Page 1

Scroll to top